800-401-4720
Recent Posts
Categories
Archives
Dangerous Drugs
Injuries
Contact Us




Dangerous Drugs and Injuiries Attorneys
Dangerous Drugs and Injuries Lawyers Who We Are What We Do Frequently Asked Questions Contact Us
We Sue Companies That Sell Dangerous Drugs
Nationwide Law Practice click here to be instantly connected to our office Medical and Legal News
August 17, 2010
  Justice Department Investigating Pharmaceutical Companies for Violation of U.S. Anti-Bribery Laws
Posted By DeCarli Law
The Financial Times reported on Thursday that the United States Department of Justice is conducting a corruption probe of several major pharmaceutical companies, including GlaxoSmithKline, Pfizer, Bristol-Myers Squibb, and Eli Lilly. Specifically, ...
Continue reading "Justice Department Investigating Pharmaceutical Companies for Violation of U.S. Anti-Bribery Laws" »

Permalink
 
August 13, 2010
  FDA Orders Label Change for Lamictal (lamotrigine) to Disclose Risk of Aseptic Meningitis
Posted By DeCarli Law
The FDA has issued a safety alert disclosing that Lamictal (lamotrigine) can cause aseptic meningitis. Lamictal (lamotrigine) is a medication commonly used to treat seizures in children two years and older, and bipolar disorder in adults. Symptoms ...
Continue reading "FDA Orders Label Change for Lamictal (lamotrigine) to Disclose Risk of Aseptic Meningitis" »

Permalink
 
August 13, 2010
  Prolactis, an Over-the-Counter Male Enhancement Supplement, Recalled Today for Containing Undeclared Drug Ingredient
Posted By DeCarli Law
The Food and Drug Administration (FDA) today ordered the recall of the male enhancement supplement Prolactis because it contains an undeclared drug ingredient. Lab analysis has found that Prolactis contains Sulfoaildenafil, an analogue of ...
Continue reading "Prolactis, an Over-the-Counter Male Enhancement Supplement, Recalled Today for Containing Undeclared Drug Ingredient" »

Permalink
 
August 12, 2010
  After Years of Delay, Bayer Asks the FDA for Approval of Gadovist, its Safer Gadolinium-Based Contrast Long Available in Europe
Posted By DeCarli Law
The FDA has just accepted Bayer Schering Pharma's New Drug Application for Gadovist, a gadolinium-based contrast agent currently sold in Europe and other parts of the world, but not in the United States. A New Drug Application is the procedure a ...
Continue reading "After Years of Delay, Bayer Asks the FDA for Approval of Gadovist, its Safer Gadolinium-Based Contrast Long Available in Europe" »

Permalink
 
August 09, 2010
  Recall of Appetite Suppressant “Solo Slim”
Posted By DeCarli Law
The FDA announced today the recall of appetite suppressants “Solo Slim” and “Solo Slim Extra Strength.” FDA lab analysis revealed that Solo Slim contains an undeclared drug ingredient, Didesmethyl Sibutramine. Sibutramine is an FDA-approved drug ...
Continue reading "Recall of Appetite Suppressant “Solo Slim”" »

Permalink
 
August 02, 2010
  DeCarli Law No Longer Accepting Fleet Cases
Posted By DeCarli Law
DeCarli Law is no longer taking new clients injured by Fleet Phospho-Soda or Fleet Phospho soda EZ Prep Bowel Cleansing System. However, DeCarli Law will continue to investigate claims for kidney injuries resulting from the oral sodium phosphate ...
Continue reading "DeCarli Law No Longer Accepting Fleet Cases" »

Permalink
 
June 21, 2010
  Federal Judge in NSF Litigation Stands By Previous Order on Expert Testimony
Posted By DeCarli Law
Another favorable ruling was issued in the federal multi-district litigation (MDL), where the claims of some people suffering from nephrogenic systemic fibrosis (NSF) are being adjudicated. On Friday, June 18, 2010, Judge Aaron Polster declined to ...
Continue reading "Federal Judge in NSF Litigation Stands By Previous Order on Expert Testimony" »

Permalink
 
June 08, 2010
  The Cleveland Plain Dealer Reports Fleet Settlement Coming Soon
Posted By DeCarli Law
The Cleveland Plain Dealer has reported that C.B. Fleet Co. is "close to reaching a final settlement" with people across the country who say their kidneys were harmed by Fleet's over-the-counter laxatives. See Diana Suchetka, "Settlement Coming in ...
Continue reading "The Cleveland Plain Dealer Reports Fleet Settlement Coming Soon" »

Permalink
 
May 11, 2010
  FDA Announces “Bad Ad Program” to Help Health Care Providers Detect and Report Misleading Drug Ads
Posted By DeCarli Law
Today, the U.S. Food and Drug Administration announced the launch of what it calls the “Bad Ad Program.” The program is designed to educate health care providers about their role in ensuring that prescription drug advertising and promotion is ...
Continue reading "FDA Announces “Bad Ad Program” to Help Health Care Providers Detect and Report Misleading Drug Ads" »

Permalink
 
May 10, 2010
  Federal Judge Rejects GE Healthcare Arguments to Exclude Expert Testimony on Cause of NSF
Posted By DeCarli Law
A recent court ruling has strengthened the legal position in federal court of those suffering from Nephrogenic Systemic Fibrosis (NSF) . A federal judge rejected the arguments of defendant GE Healthcare that plaintiffs should not be allowed to ...
Continue reading "Federal Judge Rejects GE Healthcare Arguments to Exclude Expert Testimony on Cause of NSF" »

Permalink
 
April 27, 2010
  California NSF Cases Are Consolidated in San Francisco Superior Court
Posted By DeCarli Law
Important news for Californians suffering from nephrogenic systemic fibrosis (NSF) : California NSF lawsuits have been consolidated in Department 304 of the San Francisco Superior Court, with the Honorable Richard A. Kramer presiding. This means if ...
Continue reading "California NSF Cases Are Consolidated in San Francisco Superior Court" »

Permalink
 
April 09, 2010
  New Warning of Blood Clot Risk for YAZ and Yasmin
Posted By DeCarli Law
The Associated Press is reporting that Bayer HealthCare, "[i]n cooperation with the Food and Drug Administration," has added new warnings about the risk of blood clots that come with using YAZ and Yasmin oral contraceptives . At present, the exact ...
Continue reading "New Warning of Blood Clot Risk for YAZ and Yasmin" »

Permalink
 
February 09, 2010
  Rapamycin a Possible Treatment for Nephrogenic Systemic Fibrosis (NSF)
Posted By DeCarli Law
The immunosuppressant drug rapamycin , also known as sirolimus , may help improve the symptoms of nephrogenic systemic fibrosis (NSF) , according to a Case Report published in the February 2010 Journal of the American Academy of Dermatology . NSF is ...
Continue reading "Rapamycin a Possible Treatment for Nephrogenic Systemic Fibrosis (NSF)" »

Permalink
 
January 08, 2010
  Dialysis or Kidney Transplant After Colonoscopy
Posted By DeCarli Law
If you began having serious kidney problems just weeks after a colonoscopy, the cause may have been the Fleet Phospho-Soda or Fleet Phospho soda EZ Prep Bowel Cleansing System you used before your colonoscopy. Fleet Phospho-Soda and Fleet Phospho ...
Continue reading "Dialysis or Kidney Transplant After Colonoscopy" »

Permalink
 
January 08, 2010
  8th Circuit Removes Roadblock for Ocella Injury Lawsuits
Posted By DeCarli Law
A recent decision from the 8th Circuit Court of Appeals has removed a barrier to women filing lawsuits for side effects from Ocella birth control. Ocella is the generic version of the oral contraceptive Yasmin. Drug manufacturers have taken the ...
Continue reading "8th Circuit Removes Roadblock for Ocella Injury Lawsuits" »

Permalink
 
Attorney Web Design The information on this website is for general information purposes only. Nothing on this or associated pages, documents, comments, answers, emails, or other communications should be taken as legal advice for any individual case or situation. The information on this website is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship.   DeCarli Law only represents individuals pursuant to a signed, written contract.

Address: 50 California Street, Suite 1500   San Francisco CA 94111    Toll Free: 1-800-401-4720   Phone: 1-415-738-6144

DeCarli Law represents drug side effects and defective medical devices personal injury clients for claims, lawsuits and settlements in Alabama AL, Alaska AK, Arizona AZ, Arkansas AR, California CA, Colorado CO, Connecticut CT, Delaware DE, Georgia GA, Hawaii HI, Idaho ID, Illinois IL, Kansas KS, Maine ME, Maryland MD, Massachusetts MS, Minnesota MN, Mississippi MS, Montana MT, Nebraska NE, New Hampshire NH, New Jersey NJ, New Mexico NM, New York NY, North Carolina NC, North Dakota ND, Oklahoma OK, Oregon OR, Rhode Island RI, South Carolina SC, South Dakota SD, Tennessee TN, Utah UT, Vermont VT, Virginia VA, Washington WA, Washington D.C, West Virginia WV, Wisconsin WI and Wyoming WY.  The attorneys of DeCarli Law are licensed in California and Texas.  Gadolinium lawsuits, NSF lawsuits, Nephrogenic Systemic Fibrosis Lawsuits, YAZ lawsuits, Yasmin lawsuits, Ocella lawsuits, Visicol lawsuits, OsmoPrep lawsuits.